A-111 Sub-analysis of the BELIEVE STUDY: Effectiveness and safety for retreatment with Brentuximab-vedotin in relapsed/refractory (R/R) Cutaneous T Cell Lymphoma (CTCL): a retrospective medical chart review study in Spain. NCT:04998331

Saved in:
Bibliographic Details
Published inEuropean journal of cancer (1990) Vol. 211; p. 114493
Main Authors Sureda-Balari, A., García-Sanz, R., Domingo-Domenech, E., Capote, F.J., Gutierrez, A., Rodriguez, A., Ortiz-Romero, P.L., Grande, M., Baeza-Montañez, L.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.10.2024
Online AccessGet full text

Cover

More Information
ISSN:0959-8049
DOI:10.1016/j.ejca.2024.114493